Cannabinoids in Epilepsy at DFTB17

SHARE VIA:

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

John Lawson is a paediatric neurologist at Sydney Children’s Hospital in Randwick. He has been Lead Investigator in the NSW Medical Cannabis in Epilepsy trial and is one of Australia’s leading experts on its use in near intractable seizures.

This is an almost evidence-free zone as the popular press has taken up the fight on behalf of patients.

So what are doctors to do, when parents come to them asking them to prescribe cannabis to their one year old child? This is not a talk about the wholesale legalisation of marijuana but about how, once again, we need to take a closer look at the evidence.


This double-blinded, placebo controlled trial reported in last years NEJM sets the scene for the the potential beneficial effects of cannabidiols.

Go ahead and watch the talk…

You can read this latest paper, a narrative review of some of the challenges facing the use of medical cannabis in the Medical Journal of Australia.

Chen KA, Farrar MA, Cardamone M, Lawson JA. Cannabis for paediatric epilepsy: challenges and conundrums. The Medical Journal of Australia. 2018 Feb 19;208(3):132-6.

About the authors

KEEP READING

High flow therapy – when and how?

Chest compressions in traumatic cardiac arrest

Searching for sepsis

The missing link? Children and transmission of SARS-CoV-2

Don’t Forget the Brain Busters – Round 2

An evidence summary of Paediatric COVID-19 literature

Global Developmental Delay

Urticaria

Foot x-rays

The fidget spinner craze – the good, the bad and the ugly

Parenteral Nutrition

Leave a Reply

Your email address will not be published. Required fields are marked *